CaMKK2 inhibition as an approach to increase tumor immunity in breast cancers
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Department of Defense
Start Date
July 1, 2020
End Date
December 31, 2024
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Department of Defense
Start Date
July 1, 2020
End Date
December 31, 2024